Epitope classification and RBD binding properties of neutralizing antibodies against SARS-CoV-2 variants of concern
A. Deshpande, B. D. Harris, L. Martinez-Sobrido, J. J. Kobie, M. R. Walter
This study classifies NAb epitopes against SARS-CoV-2 RBD and evaluates how variants affect NAb and ACE2 binding, identifying key mutations that impact neutralization and infectivity.
bioRxiv · Apr 13, 2021Immunology